4//SEC Filing
Danahy Kevin Patrick 4
Accession 0001437749-23-012180
CIK 0001625101other
Filed
May 1, 8:00 PM ET
Accepted
May 2, 9:45 PM ET
Size
5.4 KB
Accession
0001437749-23-012180
Insider Transaction Report
Form 4
Danahy Kevin Patrick
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2023-04-29+500,000→ 500,000 totalExercise: $6.44Exp: 2033-04-29→ Common Stock (500,000 underlying)
Footnotes (2)
- [F1]The option was granted on April 29, 2023 under the Issuer's 2017 Equity Incentive Plan. The shares subject to the option are subject to four tranches of performance-based vesting criteria tied to Issuer's market capitalization, with no vesting until the Issuer's market capitalization exceeds $1 billion, in all cases, subject to the Reporting Person's continued service through each vesting milestone.
- [F2]Not applicable.
Documents
Issuer
Pulse Biosciences, Inc.
CIK 0001625101
Entity typeother
Related Parties
1- filerCIK 0001913245
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 9:45 PM ET
- Size
- 5.4 KB